Arrow keys move between marks; Enter selects; F opens full screen.

Skip to content
Procura
Get started

Ran Biotechnologies Inc. Federal Contracts

Correct this listing

Doing business as RAN BIOTECHNOLOGIES INC

UEIUEI: the 12-character ID the government gives every company registered for federal work. It replaced the DUNS number in April 2022. Glossary YKBVQKBGGNT5· CAGECAGE code: a 5-character code that identifies one company location for federal work. A company with several sites can have several. Glossary 5DZ11· BEVERLY, MA· Active registration until Jul 13, 2027· www.ranbiotechnologies.com (opens in a new tab)

Overview

Buyers and offices that award its prime contracts, US$, active FY2021–FY2026

Obligated since award on contracts active FY2021–FY2026

Click a company to open its profile.

Buyers (sub-agency)OfficesThis companyNational Institutes ofHealth$25.9KNATIONAL INSTITUTES OF HEALTH NIAID(75N930)$25.9K · National Institutes of Health of…Ran Biotechnologies Inc.$25.9K
Awards toSubcontracts toCircle area = dollars

Insight NATIONAL INSTITUTES OF HEALTH NIAID (75N930) is its largest buyer. See more on the Buyers tab

1 buying office

Prime contract obligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary, FY2015–FY2026

$48.1K

About

From the company's SBA profile, updated Jul 2026

RAN Biotechnologies provides chemicals specially optimized for biotechnological applications, focusing on: ¬ Materials for Microfluidics: specifically surfactants for droplet microfluidics as well as surface modifications (for inertness or selective immobilization of biological). ¬ Solid Media: specifically for vaccine purification (affinity chromatography resins) and for Rapid Microbe Detection Regarding the Materials for Microfluidics business, we develop surfactants and surface coatings to stabilize droplets in microfluidics, of interest to such experiments as PCR reactions, cell analysis and drug screening. Regarding the Solid Media business, we develop insoluble resins capable of selectively capturing and controllably releasing biologicals, of interest to sterilization of fluids or purification of vaccine, and in purification of proteins for therapeutics. Moreover, we are developing solid media for detecting the presence of microbes based on color intensities.

Prime contract obligations by fiscal year, US$, FY2015–FY2026

Agencies report with a delay; the latest year will rise

Hover over a year to see its value.

FY15FY16FY22$25.9K

Insight Largest year: $25.9K in FY2022. See more on the Contracts tab

Prime obligations since award by state of performance, US$, contracts active FY2021–FY2026

Click a state to open its page.

AKMEVTNHWAIDMTNDMNILWIMINYRIMAORNVWYSDIAINOHPANJCTCAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFLPR
  1. Massachusetts$25.9K · 100%
Circle area = dollarsOutlined: head office state (Massachusetts)

Insight 100% was performed in Massachusetts. See more on the Contracts tab